244
     RDKit          2D

 18 18  0  0  0  0  0  0  0  0999 V2000
    2.0930    0.2063    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
    4.2365    1.4438    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
    2.8075    1.4438    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
    4.9509   -1.4438    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
    3.5220    0.2063    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    4.2365   -1.0313    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    4.2365   -0.2063    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    2.8075   -0.2063    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    3.5220   -1.4438    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    2.8075   -1.0313    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    3.5220    1.0313    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 H   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 H   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 H   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 H   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 H   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 H   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 H   0  0  0  0  0  0  0  0  0  0  0  0
  1  8  1  0
  2 11  1  0
  3 11  2  0
  4  6  1  0
  5  7  2  0
  5  8  1  0
  5 11  1  0
  6  7  1  0
  6  9  2  0
  8 10  2  0
  9 10  1  0
  1 12  1  0
  2 13  1  0
  4 14  1  0
  4 15  1  0
  7 16  1  0
  9 17  1  0
 10 18  1  0
M  END
>  <ALOGPS_LOGP>  (1) 
0.75

>  <ALOGPS_LOGS>  (1) 
-1.10

>  <ALOGPS_SOLUBILITY>  (1) 
1.22e+01 g/l

>  <DATABASE_ID>  (1) 
DB00244

>  <DATABASE_NAME>  (1) 
drugbank

>  <DRUGBANK_ID>  (1) 
DB00244

>  <DRUG_GROUPS>  (1) 
approved

>  <EXACT_MASS>  (1) 
153.042593095

>  <FORMULA>  (1) 
C7H7NO3

>  <GENERIC_NAME>  (1) 
Mesalazine

>  <INCHI_IDENTIFIER>  (1) 
InChI=1S/C7H7NO3/c8-4-1-2-6(9)5(3-4)7(10)11/h1-3,9H,8H2,(H,10,11)

>  <INCHI_KEY>  (1) 
KBOPZPXVLCULAV-UHFFFAOYSA-N

>  <INTERNATIONAL_BRANDS>  (1) 
Asacolitin; Claversal; Fisalamine; Iialda; Lixacol; Mesasal

>  <JCHEM_ACCEPTOR_COUNT>  (1) 
4

>  <JCHEM_AVERAGE_POLARIZABILITY>  (1) 
14.263819873124916

>  <JCHEM_BIOAVAILABILITY>  (1) 
1

>  <JCHEM_DONOR_COUNT>  (1) 
3

>  <JCHEM_FORMAL_CHARGE>  (1) 
0

>  <JCHEM_GHOSE_FILTER>  (1) 
0

>  <JCHEM_IUPAC>  (1) 
5-amino-2-hydroxybenzoic acid

>  <JCHEM_LOGP>  (1) 
-0.28978240563320434

>  <JCHEM_MDDR_LIKE_RULE>  (1) 
0

>  <JCHEM_NUMBER_OF_RINGS>  (1) 
1

>  <JCHEM_PHYSIOLOGICAL_CHARGE>  (1) 
-1

>  <JCHEM_PKA>  (1) 
15.475226170274773

>  <JCHEM_PKA_STRONGEST_ACIDIC>  (1) 
2.024188346479524

>  <JCHEM_PKA_STRONGEST_BASIC>  (1) 
5.871587939823654

>  <JCHEM_POLAR_SURFACE_AREA>  (1) 
83.55

>  <JCHEM_REFRACTIVITY>  (1) 
39.9955

>  <JCHEM_ROTATABLE_BOND_COUNT>  (1) 
1

>  <JCHEM_RULE_OF_FIVE>  (1) 
1

>  <JCHEM_TRADITIONAL_IUPAC>  (1) 
mesalazine

>  <JCHEM_VEBER_RULE>  (1) 
0

>  <MOLECULAR_WEIGHT>  (1) 
153.1354

>  <PRODUCTS>  (1) 
5-asa; Apriso; Asacol; Asacol 800; Asacol HD; Asacol Hd; Canasa; Delzicol; Lialda; Mesalamine; Mesasal; Mezavant; Ntp-5-aminosalicylic Acid; Pendo-5 Asa; Pentasa; Pentasa Enema 2g/100ml; Pentasa Extended-release Tablets 250mg; Pentasa Extended-release Tablets 500mg; Pentasa Suppository - 1g; Rowasa; Salofalk; Salofalk (r) 5-asa Enteric Coated Tab- 250mg; Salofalk (r) 5-asa Suppositories - 250mg; Teva-5 Asa; sF Rowasa; sfRowasa Sulfite-Free Formulation

>  <SECONDARY_ACCESSION_NUMBERS>  (1) 
APRD01098; DB05376; DB06396

>  <SMILES>  (1) 
NC1=CC(C(O)=O)=C(O)C=C1

>  <SYNONYMS>  (1) 
3-carboxy-4-hydroxyaniline; 5-aminosalicylic acid; 5-ASA; m-Aminosalicylic acid; Mesalamine; Mesalazina; MÃ©salazine; Mesalazinum; p-Aminosalicylsaeure

$$$$
